Nucleic Acids Research, Volume 46, Issue 2, 25 January 2018, Pages 792–803, https://doi.org/10.1093/nar/gkx1199
The authors wish to change the Conflict-of-Interest statement from:
D.E.R., D.T., I.S., S.M.P., B.D.L., C.W.Y., B.C., J.R.S, L.B. and D.J.D. are employees of Agilent Technologies. In addition, one of these authors individually owns patent rights for one of the chemical modifications used in this research.
To
D.E.R., D.T., I.S., S.M.P., B.D.L., C.W.Y., B.C., J.R.S, L.B. and D.J.D. are employees of Agilent Technologies. At the time of publication, D.J.D. individually owned patents (US Pat. Nos. 6693187, 7067641, 7745591, and 8846898) that relate to the phosphonoacetate modification used in this research.